Q-Pharm

Q-Pharm is a specialist contract research organization (CRO) based in Brisbane, Australia, focused on providing Phase 1 and early-phase clinical trial services. The company operates a high-capacity clinical unit located within the Royal Brisbane and Women's Hospital precinct, facilitating access to specialized medical facilities and diverse participant pools. Q-Pharm is recognized for its expertise in vaccine trials, infectious disease challenges, and complex pharmacokinetic studies. Following its acquisition by Nucleus Network in 2019, the facility was integrated into Australia's largest Phase 1 clinical research group and now operates under the Nucleus Network brand. The organization serves a global client base, including major pharmaceutical companies and emerging biotechnology firms seeking to leverage Australia's favorable regulatory environment and R&D tax incentives. Their facilities include a state-of-the-art bioanalytical laboratory and a dedicated clinical unit for healthy volunteer and patient-based studies.